PhaseV Unveils AI/ML Tools for Clinical Trial Design at CMO Summit
PhaseV will showcase its new AI/ML-powered clinical trial design and analysis capabilities at the CMO Summit 360° in Boston, enhancing trial success prediction and planning.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
PhaseV will showcase its new AI/ML-powered clinical trial design and analysis capabilities at the CMO Summit 360° in Boston, enhancing trial success prediction and planning.
Gestalt Diagnostics has announced a global reseller partnership with DLS Pathology Services to expand its digital pathology solutions in Australia and beyond.
Noul Co., Ltd. presented its AI-powered cervical cancer screening technology at NVIDIA GTC 2025, highlighting its miLab™ CER platform.
Brainomix has completed an $18 million Series C funding round to advance its AI imaging technology for stroke and lung fibrosis, with plans to expand in the US.
Pearl and Medit have announced a partnership to integrate AI-powered diagnostic solutions into the Medit Link platform, enhancing dental diagnostics and patient communication.
Gestalt and Primaa have announced a strategic partnership to integrate AI technology for skin cancer diagnosis into Gestalt's PathFlow platform, enhancing diagnostic precision and workflow efficiency.
Olio Labs has released a study revealing why women experience stronger side effects from GLP-1 drugs, highlighting sex-based differences in drug response.
Myant has launched Care360, an AI-driven cardiac assessment service aimed at making specialist cardiac care more accessible and preventive, according to a press release.
Tech Mahindra has announced a new pharmacovigilance solution developed with NVIDIA AI software to enhance drug safety management.
Digital Diagnostics' AI platform was recognized by NVIDIA at GTC 2025 for its role in enhancing diagnostic accuracy and accessibility in healthcare.
Northwestern Medicine and Vitestro have announced a multi-year collaboration to advance autonomous robotic phlebotomy, aiming to address staffing shortages and improve blood collection processes.
Stanford Medicine and LEADOPTIK have announced a research collaboration to explore AI-enhanced real-time optical imaging in lung biopsy procedures.
XCath has incorporated NVIDIA Isaac for Healthcare into its robotic systems to enhance stroke treatment capabilities, as announced in a press release.
Notable and CityMD have announced a multi-year partnership to implement AI and automation technology across over 180 urgent care locations, aiming to improve patient access and operational efficiency.
Subtle Medical has integrated NVIDIA's GPU architecture to advance AI-driven medical imaging, improving efficiency and image quality.
Moon Surgical has received FDA clearance for its AI-powered ScoPilot feature on the Maestro System, utilizing NVIDIA Holoscan for enhanced surgical capabilities.
Foxconn unveiled its advancements in AI, including humanoid robotics and digital twins, at NVIDIA GTC 2025, highlighting collaborations with NVIDIA.
Keralty has launched K-AI, an AI-driven global health ecosystem, to transform healthcare with predictive and personalized solutions.
brain.space has announced an $11 million Series A funding round led by Toyota Ventures to advance its Brain-Data-as-a-Service ecosystem.
Avatar Medical has received CE marking for its Avatar Medical Vision, a solution that converts medical images into 3D and XR renderings, enhancing patient and surgeon communication.